Study discovers how rare disease causing cardiovascular and cognitive disorders is triggered

November 20, 2014 by Egoitz Gago

A study has discovered the molecular mechanism that triggers homocystinuria, which is a rare disease that causes vascular and ocular disorders, skeletal deformities and mental retardation. It affects 1 in every 250,000 children born in Spain, and it has a mortality rate of 18% before the age of 30. The detection of this disease has recently been included in newborn blood spot screening.

Homocystinuria is due to a deficiency in a protein in the body called CBS. When we eat foods rich in certain amino acids, our cells produce homocysteine, which is toxic and causes homocystinuria if it accumulates. The function of CBS is precisely to 'clean' our cells of homocysteine.

In order to carry out this function, the protein has to activate, and this happens in most people. There are , however, that prevent the activation of CBS, which means that it is not able to carry out its 'cleaning' function, and leads to the development of homocystinuria.

The study, which was published recently in Proceedings of the National Academy of Sciences, revealed the morphological changes that the CBS protein undergoes when it activates.

Discovering how this protein works is a major breakthrough in the fight against homocystinuria, because it will enable research into the development of drugs that manage to activate CBS in patients suffering from this protein deficiency. If these drugs were to be developed, they would restore the normal function of this molecule and prevent the development of the disease.


This breakthrough has been possible thanks to the collaboration of two research groups led by Martínez de la Cruz from CIC bioGUNE, and Jan P Kraus, researcher at the University of Colorado. Researchers June Ereño, Tomas Majtan and Iker Oyenarte also took part in the study.

'We are highly satisfied, as the CBS protein is a very complex molecule. Several research groups have been trying for decades to discover the morphological changes that characterise its molecular activation mechanism,' says Martínez de la Cruz.

CBS protein

Last year this group discovered the structure of the CBS protein when it is inactive. This study was also published in the Proceedings of the National Academy of Sciences journal. It laid the foundations for the current breakthrough, and both studies combined have discovered the molecule's shape when it is both active and inactive.

A protein has different structures depending on whether it is active or inactive. In fact, the function of a protein is determined by its shape, so it is essential to know it in order to change the protein's behaviour.


Homocystinuria is a disease caused by deficient metabolism of methionine, an amino acid. People with this disease present genetic mutations that lead them to accumulate abnormal amounts of homocysteine, which is a product that is generated when ingesting protein in food.

These genetic mutations prevent the activation of the CBS, which is in charge of keeping the concentration of homocysteine within certain levels. If concentration levels are higher than normal and it gets into the blood plasma, it becomes toxic and turns into a large risk factor for developing vascular and , skeletal deformities and .

There is no cure for this disease, but if it is detected right after birth, some of its complications can be prevented by following a strict diet for life that is low in methionine, and by taking substances such as vitamins B6 and B12 or folic acid, which help to break down through alternative metabolic pathways. It is, therefore, convenient to detect the disease as soon as possible, which is why health authorities have included it in neonatal screening.

Explore further: 3D structure of key protein in fight against Homocystinuria unveiled

Related Stories

3D structure of key protein in fight against Homocystinuria unveiled

December 12, 2013
Homocystinuria is a disease caused by the deficiency or anomalous function of a protein, with serious consequences such as skeletal deformities, vascular thrombosis and even mental retardation. It is a disease that is classed ...

Vitamin B may not reduce risk of memory loss, study says

November 12, 2014
Taking vitamin B12 and folic acid supplements may not reduce the risk of memory and thinking problems after all, according to a new study published in the November 12, 2014, online issue of Neurology, the medical journal ...

Discovery of a new therapeutic target to fight against Legionella

September 23, 2014
Science is tightening the net around Legionella. A study conducted by the Basque Center for Cooperative Research in Biosciences, CIC bioGUNE, in collaboration with the National Institutes of Health (NIH, USA) and the Barcelona ...

Recommended for you

New approach helps rodents with spinal cord injury breathe on their own

October 17, 2017
One of the most severe consequences of spinal cord injury in the neck is losing the ability to control the diaphragm and breathe on one's own. Now, investigators show for the first time in laboratory models that two different ...

Pair of discoveries illuminate new paths to flu and anthrax treatments

October 17, 2017
Two recent studies led by biologists at the University of California San Diego have set the research groundwork for new avenues to treat influenza and anthrax poisoning.

New method to measure how drugs interact

October 17, 2017
Cancer, HIV and tuberculosis are among the many serious diseases that are frequently treated with combinations of three or more drugs, over months or even years. Developing the most effective therapies for such diseases requires ...

A new compound targets energy generation, thereby killing metastatic cells

October 17, 2017
Cancer can most often be successfully treated when confined to one organ. But a greater challenge lies in treating cancer that has metastasized, or spread, from the primary tumor throughout the patient's body. Although immunotherapy ...

Research finds that zinc binding is vital for regulating pH levels in the brain

October 17, 2017
Researchers in Oslo, Norway, have discovered that zinc binding plays an important role in the sensing and regulation of pH in the human brain. The findings come as one of the first studies that directly link zinc binding ...

Researchers find factor that delays wound healing

October 17, 2017
New research carried out at The University of Manchester has identified a bacterium—normally present on the skin that causes poor wound healing in certain conditions.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.